Trademark: 79302745
Status Date
Tuesday, August 23, 2022
Registration Number
6822946
Registration Date
Tuesday, August 23, 2022
Filing Date
Tuesday, December 1, 2020
Published for Opposition
Tuesday, June 7, 2022
5 Pharmaceutical agents affecting sensory organs; pharmaceutical products for the treatment of infectious diseases; pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for the treatment of hypercholesteremia; pharmaceutical preparations for treating hypertension; pharmaceutical preparations for the treatment of musculo-skeletal disorders; pharmaceutical preparations for the treatment of hormonal disorders; pharmaceutical preparations for treating diabetes; pharmaceutical agents affecting metabolism; pharmaceutical preparations for peripheral nervous system; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical products for the treatment of viral diseases; pharmaceuticals for the treatment of erectile dysfunction; vaccines; anti-inflammatory preparations; medicines for intestinal disorders; pharmaceutical agents affecting digestive organs; cardiovascular pharmaceutical preparations; ophthalmic preparations; biological preparations for the treatment of cancer; pharmaceutical products for the treatment of cancer; pharmaceutical agents for epidermis; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; enzymes for medical purposes; diagnostic preparations for medical or veterinary purposes; immunoassay reagents for medical use; medical reagents for testing genetic identity for medical purposes; pharmaceutical preparations for neurological disease; pharmaceutical preparations for inflammatory diseases; pharmaceutical preparations for ocular and intraocular surgery; pharmaceutical preparations for rare autoimmune diseases in the nature of autoimmune lymphoproliferative syndrome, lupus, and multiple sclerosis; pharmaceutical products for the treatment of rare autoimmune diseases and disorders; pharmaceutical products for the prevention and treatment of rare genetic diseases affecting red blood cells; medicated ointments for treating dermatological conditions; antibiotic ointments; mentholated ointment for medical use; anti-inflammatory ointments; chemical reagents for purposes of medical diagnosis; diagnostic preparations for diagnosing inflammatory diseases; diagnostic radiopharmaceutical preparations; pharmaceutical and biological preparations for use in diagnosis, namely, for use as ultrasound and X-ray contrast reagents; human vaccine preparations; pharmaceutical preparations acting on the central nervous system; preparations for the treatment of asthma; medicines for dental purposes; dermatological pharmaceutical products; pharmaceutical preparations for skin care; pharmaceutical preparations for treating skin disorders; antibiotics; anti-cancer preparations; tumor suppressing agents; pharmaceutical products for treating respiratory diseases
Dec 27, 2022
Final Decision Transaction Processed By Ib
Dec 1, 2022
Final Disposition Notice Sent To Ib
Dec 1, 2022
Final Disposition Processed
Nov 23, 2022
Final Disposition Notice Created, To Be Sent To Ib
Aug 23, 2022
Notice Of Registration Confirmation Emailed
Aug 23, 2022
Registered-Principal Register
Jul 12, 2022
Notification Of Possible Opposition - Processed By Ib
Jun 22, 2022
Notification Of Possible Opposition Sent To Ib
Jun 22, 2022
Notification Of Possible Opposition Created, To Be Sent To Ib
Jun 7, 2022
Official Gazette Publication Confirmation E-Mailed
Jun 7, 2022
Published For Opposition
May 18, 2022
Notification Of Notice Of Publication E-Mailed
May 2, 2022
Assigned To Lie
Apr 29, 2022
Approved For Pub - Principal Register
Apr 28, 2022
Teas/Email Correspondence Entered
Apr 27, 2022
Correspondence Received In Law Office
Apr 27, 2022
Teas Request For Reconsideration Received
Oct 29, 2021
Notification Of Final Refusal Emailed
Oct 29, 2021
Final Refusal E-Mailed
Oct 29, 2021
Final Refusal Written
Sep 30, 2021
Teas/Email Correspondence Entered
Sep 30, 2021
Correspondence Received In Law Office
Sep 30, 2021
Teas Response To Office Action Received
May 17, 2021
Refusal Processed By Ib
Apr 26, 2021
Non-Final Action Mailed - Refusal Sent To Ib
Apr 26, 2021
Refusal Processed By Mpu
Apr 23, 2021
Non-Final Action (Ib Refusal) Prepared For Review
Apr 22, 2021
Non-Final Action Written
Apr 21, 2021
Assigned To Examiner
Jan 26, 2021
Application Filing Receipt Mailed
Jan 22, 2021
New Application Office Supplied Data Entered In Tram
Jan 21, 2021
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
